Inflammation and accelerated atherosclerosis: Basic mechanisms

Rheumatic Disease Clinics of North America

Volumn 31, Issue 2, 2005, Pages 355-362

  Doria, Andrea ^a   Sherer, Yaniv ^b   Meroni, Pier L ^c   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; CD40 LIGAND MONOCLONAL ANTIBODY; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE DISEASE; CARDIOVASCULAR RISK; CELLULAR IMMUNITY; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR ENDOTHELIUM;

ARTERIOSCLEROSIS; HUMANS; RHEUMATIC DISEASES;

EID: 19544366261     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.01.006     Document Type: Review

References (44)

1. Y. Shoenfeld Atherosclerosis and the immune system: is atherosclerosis an autoimmune disease? Seminars in Clinical Immunology 1 2000 5 6
2. Y. Shoenfeld, Y. Sherer, and D. Haratz Atherosclerosis as an infectious, inflammatory and autoimmune disease Trends Immunol 22 2001 293 295
3. Y. Sherer, and Y. Shoenfeld Atherosclerosis: is atherosclerosis a cellular or humoral mediated autoimmune disease? Ann Rheum Dis 61 2002 97 99
4. J. George, D. Harats, and Y. Shoenfeld Inflammatory and immune aspects of atherosclerosis Isr Med Assoc J 1 1999 112 116
5. R. Ross Atherosclerosis - an inflammatory condition N Engl J Med 340 1999 115 126
6. E.E. Emeson, M.L. Shen, and C.G. Bell Inhibition of atherosclerosis in CD4 T-cell-depleted and nude (nu/nu) C57BL/6 hyperlipidemic mice Am J Pathol 149 1996 675 685
7. X. Zhou, A. Nicoletti, and R. Elhage Transfer of CD4 + T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice Circulation 102 2000 2919 2922
8. J. George, D. Harats, and B. Gilburd Immunolocalization of β2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression Circulation 99 1999 2227 2230
9. J. George, D. Harats, and B. Gilburd Adoptive transfer of beta-2-glycoprotein-I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice Circulation 102 2000 1822 1827
10. J. George, A. Afek, and B. Gilburd Cellular and humoral immune responses to heat shock protein both involved in promoting fatty-streak formation in LDL-deficient mice J Am Coll Cardiol 38 2001 900 905
11. J. George, A. Afek, and B. Gilburd Atherosclerosis in LDL-receptor knockout mice is accelerated by immunization with anticardiolipin antibodies Lupus 6 1997 723 729
12. A. Afek, J. George, and Y. Shoenfeld Enhancement of atherosclerosis in beta-2-glycoprotein I-immunized apolipoprotein E-deficient mice Pathobiology 67 1999 19 25
13. J. George, A. Afek, and B. Gilburd Induction of early atherosclerosis in LDL-receptor-deficient mice immunized with beta2-glycoprotein I Circulation 98 1998 1108 1115
14. R. Wu, and A.K. Lefvert Autoantibodies against oxidized low density lipoproteins (oxLDL): characterization of antibody isotope, subclass, affinity and effect on the macrophage uptake of oxLDL Clin Exp Immunol 102 1995 174 180
15. C. Bergmark, R. Wu, and U. de Faire Patients with early onset of peripheral vascular disease have high levels of autoantibodies against oxidized low-density lipoproteins Arterioscler Thromb Vasc Biol 15 1995 441 445
16. Wu R., Shoenfeld Y., Matucci M., et al. Nontraditional factors vary in patients with autoimmune diseases. Clin Invest Med, in press
17. R. Wu, E. Svenungsson, and I. Gunnarsson Antibodies against lysophosphatidylcholine and oxidized LDL in-patients with SLE Lupus 8 1999 142 150
18. R. Wu, E. Svenungsson, and I. Gunnarsson Antibodies to adult human endothelial cells cross-react with oxidized LDL and β2-glycoprotein I in SLE Clin Exp Immunol 115 1999 561 566
19. J. George, A. Afek, and B. Gilburd Hyperimmunization of apo-E mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis Atherosclerosis 138 1998 147 152
20. R. Wu, L. Dearing, and E. Matsuura Are anti-oxLDL antibodies pathogenic or protective? Circulation 110 2004 2252 2258
21. D. Nicolo, B.I. Goldman, and M. Monestier Reduction of atherosclerosis in low-density lipoprotein receptor-deficient mice by passive administration of antiphospholipid antibody Arthritis Rheum 48 2003 2974 2978
22. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
23. D.B. Cines, E.S. Pollak, and C.A. Buck Endothelial cells in physiology and in the pathophysiology of vascular disorders Blood 91 1998 3527 3561
24. A.L. Rothermel, Y. Wang, and J. Schechner Endothelial cells present antigens in vivo BMC Immunol 16 2005 5 24
25. J. Acosta, X. Qin, and J. Halperin Complement and complement regulatory proteins as potential molecular targets for vascular diseases Curr Pharm Des 10 2004 203 211
26. F. Niculescu, and H. Rus The complement activation in atherosclerosis Immunol Res 30 2004 73 80
27. P.L. Meroni, E. Raschi, and C. Testoni Functional heterogeneity of pathogenic anti-endothelial antibodies Y. Shoenfeld D. Harats G. Wick Atherosclerosis and autoimmunity 2001 Elsevier Amsterdam 211 220
28. J. George, P.L. Meroni, and B. Gilburd Antiendothelial cell antibodies in patients with coronary atherosclerosis Immunol Lett 73 2000 23 27
29. A. Farsi, M.P. Domeneghetti, and T. Brunelli Activation of the immune system and coronary artery disease: the role of antiendothelial cell antibodies Atherosclerosis 154 2001 429 436
30. W.P. Faulk, M. Rose, and P.L. Meroni Antibodies to human endothelial cells identify myocardial damage and predicts development of coronary artery disease in patients with transplanted hearts Hum Immunol 60 1999 826 832
31. K.N. Lai, J.C. Leung, and K.B. Lai Upregulation of adhesion molecules on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus Clin Immunol Immunopathol 81 1996 229 238
32. P.L. Meroni, E. Raschi, and C. Testoni Endothelial cell activation by antiphospholipid antibodies Clin Immunol 112 2004 169 174
33. P. Libby, P. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
34. P.O. Bonetti, O.L. Lilach, and A. Lerman Endothelial dysfunction. A marker of atherosclerotic risk Arterioscler Thromb Vasc Biol 23 2003 168 175
35. Y. Sherer, and Y. Shoenfeld Immunomodulation for treatment and prevention of atherosclerosis Autoimmun Rev 1 2002 21 27
36. E. Toubi, and Y. Shoenfeld The role of DC40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway Autoimmunity 37 2004 457 464
37. D. Harats, N. Yacov, and B. Gilburd Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions J Am Coll Cardiol 7 2002 1333 1338
38. O. Shovman, Y. Levy, and B. Gilburd Anti-inflammatory and immunomodulatory properties of statins Immunol Res 25 2002 271 285
39. S. Shapiro, Y. Shoenfeld, and B. Gilburd Intravenous gamma globulin inhibits the production of matrix metalloproteinase-9 in macrophages Cancer 95 2002 2032 2037
40. P.L. Meroni, C. Luzzana, and D. Ventura Anti-inflammatory and immunomodulating properties of statins. An additional tool for the therapeutic approach of systemic autoimmune diseases? Clin Rev Allergy Immunol 23 2002 263 277
41. A. Nicoletti, S. Kaveri, and G. Caligiuri Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice J Clin Invest 102 1998 910 918
42. R. Wu, Y. Shoenfeld, and Y. Sherer Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations-possible immunomodulation of atherosclerosis Autoimmunity 36 2003 91 97
43. N. Ronda, S. Leonardi, and G. Orlandini Natural antiendothelial cell antibodies (AECA) J Autoimmun 13 1999 121 127
44. N. Ronda, F. Bernini, and R. Giacosa Normal human IgG prevents endothelial cell activation induced by TNFα and oxidized low-density lipoprotein atherogenic stimuli Clin Exp Immunol 133 2003 219 226